Navigation Links
WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2012 Results, Share Repurchase Program
Date:3/7/2013

nagement Comment"WuXi is succeeding on three fronts: growing, investing to sustain our growth, and returning capital to shareholders," said Dr. Ge Li, Chairman and Chief Executive Officer.  "We achieved strong double-digit revenue growth in the fourth quarter and full year of 2012.  We also achieved double-digit growth in earnings per ADS in 2012.  We continued to invest to build capabilities and capacity in order to sustain revenue and earnings growth for the long term.  While growing and investing, we generated strong free cash flow that allowed us to purchase our shares.

"I am proud of what we accomplished in 2012," Dr. Li continued.  "Revenue growth of 22.8% to about $500 million was driven by continuing growth in demand for WuXi's services in all of our businesses.  In February, we opened a chemistry facility in Wuhan to give our customers a new pricing option.  In October, we began operation of a new cGMP drug-substance biologics manufacturing facility in Wuxi.  We signed many new contracts in biologics, including a joint venture with MedImmune to co-develop their anti-IL6 monoclonal antibody for the China market. We delivered nine small molecule preclinical drug candidates for our clients.  We produced advanced intermediates for five commercial products and grew our late-stage manufacturing pipeline.  The company entered into an agreement to form a joint venture with PRA to offer clinical research services in China.  We purchased 7% of our ADSs outstanding at the beginning of the year.  WuXi achieved year-over-year growth in GAAP diluted EPS of 10.8% and in non-GAAP diluted EPS of 13.3%.  And we continued to invest in building new capabilities and capacities with $67.8 million in new capital assets, to drive future revenue and income growth.

"2013 looks to be another good year.  We expect 13-15% revenue growth, driven by increasing demand across our service offerings.  In
'/>"/>

SOURCE Wuxi PharmaTech Co. Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. WuXi PharmaTech and Open Monoclonal Technology Expand Human Antibody Development and Commercial Opportunities for Asian Regional and Global Pharmaceutical Companies
2. WuXi PharmaTech Schedules Fourth-Quarter 2012 Earnings Release
3. WuXi PharmaTech Presents the 2012 Life Science and Chemistry Awards
4. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2012 Annual General Meeting
5. WuXi PharmaTech Celebrates Dr. Joseph Vaccas Induction into American Chemical Societys Medicinal Chemistry Hall of Fame
6. WuXi PharmaTech and Open Monoclonal Technology Announce OmniRat(TM) Antibody Collaboration
7. WuXi PharmaTech to Manufacture Ibalizumab for TaiMed Biologics
8. WuXi PharmaTech Receives GLP Certificate from SFDA for Suzhou Toxicology Facility
9. WuXi PharmaTech Announces Second-Quarter 2012 Results
10. Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
11. WuXi PharmaTech Announces First-Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/dl9gbg/admetoxicology ... Testing - Global Strategic Business Report" report to ... markets for ADME-Toxicology Testing in US$ Million by the ... Testing. The report provides separate comprehensive analytics ... Japan , Europe , ...
(Date:4/17/2015)...  Trovagene, Inc., (NASDAQ:  TROV) a developer of ... presented at the 2015 European Lung Cancer Conference ... ℠ (PCM) platform outperformed tissue biopsy for ... mutations in metastatic lung cancer patients. The ... in Urinary Circulating Tumor DNA from Metastatic Non-Small ...
(Date:4/17/2015)... and Markets ( http://www.researchandmarkets.com/research/vrd3bd/mammography ) has announced ... Strategic Business Report" report to their offering. ... Equipment in US$ Thousands by the following Product Segments: ... provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ...
Breaking Medicine Technology:ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015: Pharma Industry Renews Focus on Cost Optimization 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4Mammography Equipment (Analog & Digital) Market 2015-2020 - Global Strategic Business Report: Breast Imaging Screening Programs Push Sales 2
... , WALTHAM, Mass., Nov. ... authority on medical technology market intelligence, policy changes made by ... a surge in obstructive sleep apnea (OSA) diagnostic testing and ... Sleep Management Devices 2010 report finds that increasing reimbursement ...
... Nov. 16 Epilepsy and seizures affect nearly 3 million Americans ... cause is apparent. Those who live daily with the condition have ... long it will last or where they will be, often experiencing ... The wonder behind the diagnosis, the perseverance in managing it, ...
Cached Medicine Technology:Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16% as CMS Reimbursement Expands 2Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16% as CMS Reimbursement Expands 3National Expressions of Courage Art Contest Unveils Stories of Inspiration 2National Expressions of Courage Art Contest Unveils Stories of Inspiration 3National Expressions of Courage Art Contest Unveils Stories of Inspiration 4National Expressions of Courage Art Contest Unveils Stories of Inspiration 5
(Date:4/18/2015)... Lower-auto-insurance.com has released a new blog post explaining how ... , Drivers can find accurate information about various ... brokerage website can help drivers compare the newest and ... The whole process is designed to be convenient, free ... insurance quotes is advantageous because it allows clients to ...
(Date:4/18/2015)... 2015 Thousand of DePuy Pinnacle hip ... individuals who were allegedly harmed by a metal-on-metal version ... in the U.S. District Court, Northern District of Texas. ... has amended an earlier Case Management Order to allow ... the new amendment permits the claims of up to ...
(Date:4/18/2015)... More than 2000 styles of newly designed prom ... online store carrying celebrity inspired special occasion dresses. With ... perfect dresses for their prom. For those who are ... TheCelebrityDresses.com would be an ideal choice. , "We ... inspired by the most loved styles seen at this ...
(Date:4/18/2015)... April 18, 2015 Aureus Medical ... staffing, including physical therapy jobs, has announced that ... South Carolina Physical Therapy Association Annual Conference to ... Center in Greenville, SC. , The SCAPTA ... exhibits with products and services. , Representatives ...
(Date:4/18/2015)... PHOENIX, ARIZONA – In March, Mark Ona, ... secure destruction professionals across the United States, earned the ... now display “CSDS” as a professional title with his ... Association of Information Destruction 2015 Annual Conference began - ... the 20 people who took the exam, Ona was ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Quotes Can Provide Accurate Results! 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 3Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the South Carolina Physical Therapy Association Annual Conference 2
... BRONX, NY - In an important finding published ... Einstein College of Medicine of Yeshiva University, along with ... protein likely responsible for causing breast cancer to spread. ... the original tumor travel to distant sites via the ...
... to identify a disease whether it is common ... people think the condition is, according to new research ... study on how people understand and interpret disease. ... Public Library of Science: ONE , examined many recently ...
... a malaria vaccine progress to Phase 3 trials following the ... month old children in Korogwe, Tanzania and coastal Kenya, which ... Medicine (NEJM) . , In a separate paper, which ... presented of the first co-administration of the RTS, S/AS02 malaria ...
... to Get Kids Vaccinated , ... (Vocus) December 8, 2008 -- Losing ... Families Fighting Flu (FFF) , it is a tragedy they have experienced ... lost a child to the flu or have had a child experience ...
... Dec. 8 The independent, non-profit, eHealth ... records for every doctor,s office and hospital in ... elements of which were announced as part of ... ( http://change.gov/newsroom/entry/the_key_parts_of_the_jobs_plan/ ). , ...
... time, increases accuracy of medication supply, and provides chain ... ORLANDO, Fla., Dec. 8 Aethon Inc ... hospital supply chain logistics, announced today at the American ... has developed a patent-pending replenishment solution for Automated Dispensing ...
Cached Medicine News:Health News:Einstein researchers discover protein that contributes to cancer spread 2Health News:Einstein researchers discover protein that contributes to cancer spread 3Health News:Medical terms worry more people than lay terms, study finds 2Health News:Promising trials of malaria vaccine lead to calls for Phase 3 development 2Health News:Promising trials of malaria vaccine lead to calls for Phase 3 development 3Health News:For Kids, the Flu Can Be Severe, Even Deadly 2Health News:For Kids, the Flu Can Be Severe, Even Deadly 3Health News:eHealth Initiative Applaudes President-Elect Obama's Recognition of the Importance of Information Technology to Improve U.S. Health Care System 2Health News:Aethon Develops First-Ever Solution for Automated Replenishment of Pharmacy ADCs 2Health News:Aethon Develops First-Ever Solution for Automated Replenishment of Pharmacy ADCs 3
The Select Series® Arterial Cannulae utilize a state-of-the-art dip-molding technology. This process allows molding of a one-piece, wire-wound cannula that is flexible and kink-resistant....
Intermittent catheter...
... a rapid and accurate bedside test for the ... diagnosis and assessment of patients with suspected Congestive ... and accuracy profit from a test combining ... 12 minutes. In emergency departments Point of Care ...
... Finnpipette Focus from Thermo Labsystems was designed ... Advanced features such as the new ... adjustment on microvolumes help to define this ... pipettes. The new interchangeable handle plate offers ...
Medicine Products: